Maxmarvil awarded as the 100 outstanding patented products.

Published: 2006-01-18 06:55:00

Updated: 2006-01-18 06:55:00

Maxmarvil, a combined anti-osteoporosis drug developed by Yuyu, was awarded by the Patent Office for an outstanding patented product in the 4th top 100 outstanding patented product award occasion on Jan. 12.

The award occasion was held under the auspice of the Korea Daily News and sponsored by...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK